Differences in anti-inflammatory actions of intravenous immunoglobulin between mice and men: more than meets the eye

Differences in anti-inflammatory actions of intravenous immunoglobulin between mice and men: more than meets the eye

Intravenous immunoglobulin (IVIg) is a therapeutic preparation of polyspecific human IgGs purified from plasma pooled from thousands of individuals. When administered at a high dose, IVIg inhibits inflammation and has proven efficacy in the treatment of various autoimmune and systemic inflammatory d...

Full description

Bibliographic Details
Main Authors:	Angela SW eTjon, Rogier evan Gent, Teunis B eGeijtenbeek, Jaap eKwekkeboom
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2015-04-01
Series:	Frontiers in Immunology
Subjects:	regulatory T cells IVIg sialylation Fcγ receptors Anti-inflammatory mechanisms
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00197/full

Similar Items

Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation
by: Christopher Beneduce, et al.
Published: (2023-08-01)

The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin
by: Fabian Bohländer, et al.
Published: (2021-12-01)

Intravenous Immunoglobulin Therapy in COVID-19 Disease
by: Öner Özdemir, et al.
Published: (2021-06-01)

Minimal B Cell Extrinsic IgG Glycan Modifications of Pro- and Anti-Inflammatory IgG Preparations in vivo
by: Anja Schaffert, et al.
Published: (2020-01-01)

Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
by: Thomas Rogier, et al.
Published: (2020-06-01)

The Role of Fc Gamma Receptors in Broad Protection against Influenza Viruses
by: Natalie K. Thulin, et al.
Published: (2018-06-01)

The therapeutic window of intravenous immunoglobulin (IVIG) and its correlation with clinical outcomes in Kawasaki disease: a systematic review and meta-analysis
by: Zheng Li, et al.
Published: (2023-04-01)

Comparative study between the efficacy of Intravenous Immunoglobulin alone versus the efficacy of Intravenous Immunoglobulin combined with Steroids in treatment of Acute Myocarditis in Pediatric patients in Qena University Hospital
by: Alaa Abd El-sabour Bashier, et al.
Published: (2024-01-01)

Intravenous immunoglobulin: A potential treatment for the post-acute sequelae of SARS-Cov-2 infection?
by: Sandra Reznik, et al.
Published: (2022-07-01)

Long-Term Hypermethylation of <i>FcγR2B</i> in Leukocytes of Patients with Kawasaki Disease
by: Ling-Sai Chang, et al.
Published: (2021-05-01)

New insight into the intravenous immunoglobulin treatment in Multisystem Inflammatory Syndrome in children and adults
by: Chih-Jen Chen, et al.
Published: (2024-01-01)

Parameters Associated with the Required Drug Dose of Intravenous Immunoglobulin in Stable Chronic Inflammatory Demyelinating Polyradiculoneuropathy
by: Ludger Feyen, et al.
Published: (2023-03-01)

Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream
by: Neda Shahriari, MD, et al.
Published: (2023-02-01)

Pregnancy associated anti-TIF1 dermatomyositis responsive to intravenous immunoglobulin
by: Jason Kieffer, MD, et al.
Published: (2024-03-01)

Intravenous immunoglobulin suppresses the polarization of both classically and alternatively activated macrophages
by: Chaitrali Saha, et al.
Published: (2020-02-01)

Pharmacogenomics of intravenous immunoglobulin response in Kawasaki disease
by: Sadeep Shrestha, et al.
Published: (2024-01-01)

Thymic-derived tolerizing dendritic cells are upregulated in the spleen upon treatment with intravenous immunoglobulin in a murine model of immune thrombocytopenia
by: Rick Kapur, et al.
Published: (2017-07-01)

Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report
by: Maryam Daneshpazhooh, et al.
Published: (2020-07-01)

Use of Intravenous Immunoglobulins in Sepsis Therapy—A Clinical View
by: Dominik Jarczak, et al.
Published: (2020-08-01)

Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
by: Tsvetelina Velikova, et al.
Published: (2023-03-01)

The use of furosemide during Intravenous Immunoglobulin therapy should not always be considered contraindicated
by: Serdar EFE, et al.
Published: (2024-02-01)

Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients
by: Dorota Kwapisz, et al.
Published: (2023-07-01)

Erratum: Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
by: Frontiers Production Office
Published: (2022-04-01)

Relationship between Body Composition and Serum Immunoglobulin Concentrations after Administration of Intravenous Immune Globulin–Preclinical and Clinical Evidence
by: Luigi Brunetti, et al.
Published: (2023-02-01)

Intravenous Immunoglobulin (IVIG) Therapy for COVID-19 Omicron (B.1.1.529) Variant with Acute Respiratory Distress Syndrome
by: Dewi Arum Sawitri, et al.
Published: (2023-01-01)

Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin
by: Jorge Adrian Masso-Silva, et al.
Published: (2022-10-01)

Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients
by: Rui Zhang, et al.
Published: (2023-06-01)

Case Report: Rheumatoid meningitis with positive NMDAR antibody: A case treated with intravenous immunoglobulin
by: Honglian Zhang, et al.
Published: (2022-10-01)

Injection of intravenous immunoglobulin (IVIg) for the treatment of Coronavirus induced cytokine storm
by: Farahnoosh Farnood, et al.
Published: (2022-12-01)

A case of nivolumab-induced scleroderma-like syndrome successfully treated with intravenous immunoglobulin
by: Alexa DeMaio, MD, et al.
Published: (2023-01-01)

Is dosing of therapeutic immunoglobulins optimal? – A review of a 3-decade long debate in Europe.
by: Jacqueline eKerr, et al.
Published: (2014-12-01)

Prediction of intravenous immunoglobulin retreatment in children with Kawasaki disease using models combining lymphocyte subset and cytokine profile in an East Asian cohort
by: Chun Zhang, et al.
Published: (2024-01-01)

Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis
by: Xiaosheng Liu, et al.
Published: (2023-01-01)

Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
by: Zahra Farahmandinia, et al.
Published: (2010-10-01)

Comparison of Intravenous Immunoglobulin (IVIG) and Intravenous anti-D for Treatment of Acute Idiopathic Thrombocytopenic Purpura
by: Zahra Farahmandinia, et al.
Published: (2010-12-01)

Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity
by: Cristina Meregalli, et al.
Published: (2021-01-01)

Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis
by: Colin Anderson-Smits, et al.
Published: (2023-05-01)

Maintenance Intravenous Immunoglobulin Treatment for Multiple Sclerosis Coexisting with Ehlers-Danlos Syndrome and Muir-Torre Syndrome: A Case Study
by: Srishti Gupta, et al.
Published: (2020-08-01)

Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency
by: Bob Geng, et al.
Published: (2023-02-01)

Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis
by: Hong Xin, et al.
Published: (2023-02-01)